Mark Cuban

Right now, I'm losing money. And most of that was because we built a factory, a whole robotics driven factory that manufactures sterile injectables that are in short supply.

So now, like with the hurricane, you know, we're using our robotics to switch over to sterile water of all things and some other things so that we can manufacture it and get it to them at a reasonable price as opposed to price gouging. which Kamala has talked often about. So, you know, because there will be price gouging in pharmacy and we're here to be an alternative.

So now, like with the hurricane, you know, we're using our robotics to switch over to sterile water of all things and some other things so that we can manufacture it and get it to them at a reasonable price as opposed to price gouging. which Kamala has talked often about. So, you know, because there will be price gouging in pharmacy and we're here to be an alternative.

So to answer your question, I've spent a whole lot of money on these robotics and putting this together. But our path is hockey stick, double, triple hockey stick. And so we're taking business from them. And I think the traditional legacy companies in the insurance.

So to answer your question, I've spent a whole lot of money on these robotics and putting this together. But our path is hockey stick, double, triple hockey stick. And so we're taking business from them. And I think the traditional legacy companies in the insurance.

So both. What happened was I got an email from my partner, co-founder, Dr. Alex Oshmayansky. And he wanted to create a compounding pharmacy in Denver that made drugs that were in short supply. Because there's always, for whatever reason, some generic drug that is on a shortage list. And I'm like, you're thinking too small. And this was right around the time that the pharma bro was going to jail.

So both. What happened was I got an email from my partner, co-founder, Dr. Alex Oshmayansky. And he wanted to create a compounding pharmacy in Denver that made drugs that were in short supply. Because there's always, for whatever reason, some generic drug that is on a shortage list. And I'm like, you're thinking too small. And this was right around the time that the pharma bro was going to jail.

And I asked him, how is it that this dude buys up a one-year supply of Daraprim, the drug he bought, and just jacks it up? And how does that happen? And he goes, it just happened. I'm like, well, let me do some homework and dig in. And the reason was obvious. The industry was completely opaque.

And I asked him, how is it that this dude buys up a one-year supply of Daraprim, the drug he bought, and just jacks it up? And how does that happen? And he goes, it just happened. I'm like, well, let me do some homework and dig in. And the reason was obvious. The industry was completely opaque.

The first line in every single pharmacy contract and health care contract for that matter is you're not allowed to talk about it. You are restricted from talking about this to anybody, anybody at all. So we had a completely opaque market. So we put together the website called costplusdrugs.com.

The first line in every single pharmacy contract and health care contract for that matter is you're not allowed to talk about it. You are restricted from talking about this to anybody, anybody at all. So we had a completely opaque market. So we put together the website called costplusdrugs.com.

But really the smartest thing that we did, and it was unintentional in terms of impact, we created a full price list. So you can get our 2,500 drugs, the actual price list, and we release it every week because we're on a roll now where we've had since last a year ago, more than a year ago, every weekday we've lowered a price on a drug. And so we just put that out.

But really the smartest thing that we did, and it was unintentional in terms of impact, we created a full price list. So you can get our 2,500 drugs, the actual price list, and we release it every week because we're on a roll now where we've had since last a year ago, more than a year ago, every weekday we've lowered a price on a drug. And so we just put that out.

And what's happened as a result is now companies can just get the price list

And what's happened as a result is now companies can just get the price list

So we put out this price list and all of a sudden Harvard Medical and Vanderbilt and all these research institutes took our pricing and compared it to what Medicare was paying for the same drugs.

So we put out this price list and all of a sudden Harvard Medical and Vanderbilt and all these research institutes took our pricing and compared it to what Medicare was paying for the same drugs.

Yeah.

Yeah.

and this is sort of maybe ties together with the governmental efficiency and just do the obvious right thing but shouldn't they just work with you as an example and and why don't they they are and it's just starting they are right so here's again i can't speak for her to say what she's going to do but here was the conversation i've had with her team when it comes to reducing out-of-pocket costs to deal with inflation what i've told them is